Hanshu Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
About Hanshu Pharmaceuticals
Hanshu Pharmaceuticals Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2019 (Five years and two months 16 days old ). Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Swapan Chakraborty, Sushil Vimal, Himani Vimal, and One other member serve as directors at the Company.
Company Details
-
Location
Panchkula, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230HR2019PTC083733
-
Company No.
083733
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Nov 2019
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Hanshu Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapan Chakraborty
|
Additional Director | 17-Mar-2020 | Current |
|
Sushil Vimal
|
Director | 20-Nov-2019 | Current |
|
Himani Vimal
|
Director | 20-Nov-2019 | Current |
|
Jatinder Singh
|
Additional Director | 16-Apr-2021 | Current |
Financial Performance of Hanshu Pharmaceuticals.
Enhance accessibility to Hanshu Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hanshu Pharmaceuticals?
Unlock access to Hanshu Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Himrose Biotech Private LimitedSushil Vimal and Himani Vimal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hanshu Pharmaceuticals?
Unlock and access historical data on people associated with Hanshu Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hanshu Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hanshu Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.